Skip to content

News
 

CHI Board of Directors

CHI Chairman
Henry L. Nordhoff
Chairman & CEO
Gen-Probe Incorporated

CHI President & CEO
David L. Gollaher, Ph.D.
California Healthcare Institute

David W. Beier
Senior Vice President Global Government Affairs
Amgen

Hans Bishop
President, Hematology/Cardiology
EVP, Bayer HealthCare LLC

John A. Cottingham
Senior Vice President, General Counsel and Corporate Secretary
Invitrogen Corporation

John M. Dunn
Executive Vice President, New Ventures
Biogen Idec

David D. Fleming

David D. Fleming
Group Sr. VP & Corporate Officer
Genzyme Corporation

Scott Garrett

Scott Garrett
President and Chief Executive Officer
Beckman Coulter, Inc.

Chairman, CHI Finance Committee
Lawrence P. Guiheen
President
Baxter BioPharmaceuticals Baxter BioScience

Robert B. Hance

Robert B. Hance
President, Vascular

Abbott Vascular

Chairman, Biopharmaceutical Sector Policy Committee
Stephen G. Juelsgaard
Executive VP, Secretary & Chief Compliance Officer
Genentech

Louis G. Lange, M.D., Ph.D.
Chairman and Chief Executive Officer.
CV Therapeutics, Inc

Chairman, CHI Audit Committee
Tracy T. Lefteroff
Global Managing Partner, Life Sciences Industry
PricewaterhouseCoopers

Chairman, CHI Membership Committee
Ted W. Love, M.D.
Chairman & CEO
Nuvelo, Inc.

Alexis V. Lukianov
Chairman of the Board & CEO
NuVasive

Chairman, CHI Nominating and Governance Committee
John C. Martin, Ph.D.
Chairman of the Board & CEO
Gilead Sciences

BOD - Peter Milner - sm

Peter G. Milner, M.D.
President, Co-Founder, Member Board of Directors
ARYx Therapeutics, Inc.

Chairman, Medical Technologies Sector Policy Committee
Michael A. Mussallem
Chairman & CEO
Edwards Lifesciences

Chairman, Research & Education Sector Policy Committee
Gail K. Naughton, Ph.D.
Dean, College of Business Administration
San Diego State University

Christian W. Nolet
Partner & Co-Director for Lifesciences, California Region
Ernst & Young

Christopher J. O'Connell

Christopher J. O'Connell
Senior Vice President, and President, Diabetes
Medtronic Diabetes

Daniel O'Day

Daniel O'Day
President and Chief Executive Officer
Roche Molecular Diagnostics

Michael Onuscheck

Michael Onuscheck
President of the Neuromodulation Division
Boston Scientific

Richard P. Patrylak
Sr. VP, Customer Sales, Marketing and Policy
Merck & Company

Philip A. Pizzo, M.D.
Dean of the School of Medicine
Stanford University

David E. I. Pyott
Chairman of the Board & CEO
Allergan 

BOD - William Rhodes - sm

William E. Rhodes
President, Cell Analysis
BD Biosciences

George Scangos

George Scangos
President and Chief Executive Officer
Exelixis

BOD - Thomas West - sm

Thomas A. West
President of North America
LifeScan, Inc.